Bernie Sanders, Vermont's junior senator with a penchant for deeming things "outrageous," proudly relates on his website how he took constituents across the border to (illegally) buy cheaper prescription drugs in Canada.

This week, the Associated Press reports, the Senate rejected a plan to let Americans import low-cost prescriptions from abroad. "White House officials have denied accusations ... that the administration was opposing importation as a way of retaining the drug industry's support for Obama's health care overhaul legislation, the president's top domestic priority," reports the AP.

How much of a role do you think the powerful drug and health-care lobbies should have? Among its top 10 spenders in 2009, the Center for Responsive Politics lists AARP at No. 8, Pfizer at No. 6, Blue Cross/Blue Shield at No. 5, and Pharmaceutical Research & Manufacturers of America -- whose members include such heavy-hitters as Abbott Labs (NYSE:ABT), Amgen (NASDAQ:AMGN), Pfizer (NYSE:PFE), and Merck (NYSE:MRK) -- at No. 3.

Sound off in the comments box below. For each post, the Fool will donate $0.10 to the Thurgood Marshall Academy in Washington, D.C., in furtherance of financial literacy.

Fool online editor Kris Eddy owns no shares of any stocks mentioned in this article. Try any of our investing newsletters free for 30 days. The Fool has a disclosure policy.